A detailed history of Atlas Capital Advisors LLC transactions in Haleon PLC stock. As of the latest transaction made, Atlas Capital Advisors LLC holds 2,885 shares of HLN stock, worth $28,907. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,885
Previous 2,885 -0.0%
Holding current value
$28,907
Previous $24.5 Million 2.71%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

SELL
$8.02 - $8.67 $65,138 - $70,417
-8,122 Reduced 73.79%
2,885 $24.5 Million
Q4 2023

Feb 15, 2024

BUY
$7.78 - $8.62 $17,186 - $19,041
2,209 Added 25.11%
11,007 $90.6 Million
Q3 2022

Nov 08, 2022

BUY
$5.63 - $7.5 $49,532 - $65,985
8,798 New
8,798 $53.6 Million

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $46.3B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Atlas Capital Advisors LLC Portfolio

Follow Atlas Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Capital Advisors LLC with notifications on news.